Literature for PR-924 (T01.015 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2014
1. Kisselev,A.F. and Groettrup,M.
   Subunit specific inhibitors of proteasomes and their potential for immunomodulation
   Curr Opin Chem Biol23, 16-22. PubMed  Europe PubMed DOI  I
2. Niewerth,D., van Meerloo,J., Jansen,G., Assaraf,Y.G., Hendrickx,T.C., Kirk,C.J., Anderl,J.L., Zweegman,S., Kaspers,G.J. and Cloos,J.
   Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924
   Biochem Pharmacol89, 43-51. PubMed  Europe PubMed DOI  I
2011
3. Singh,A.V., Bandi,M., Aujay,M.A., Kirk,C.J., Hark,D.E., Raje,N., Chauhan,D. and Anderson,K.C.
   PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo
   Br J Haematol152, 155-163. PubMed  Europe PubMed DOI  I